Contrast-enhanced cardiac magnetic resonance in a patient with chemotoxic cardiomyopathy

J Cardiovasc Med (Hagerstown). 2007 Mar;8(3):214-5. doi: 10.2459/JCM.0b013e3280104155.

Abstract

Gadolinium-enhanced cardiac magnetic resonance was performed in a patient with chemotoxic cardiomyopathy. Intramyocardial midwall linear delayed hyperenhancement was found. Such a finding is consistent with midwall fibrosis and/or myocardial cell loss due to cardiotoxic effect of chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / physiopathology
  • Contrast Media*
  • Cyclophosphamide / adverse effects
  • Doxorubicin / adverse effects
  • Humans
  • Magnetic Resonance Imaging, Cine* / methods
  • Male
  • Stroke Volume
  • Vincristine / adverse effects

Substances

  • Contrast Media
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide